Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma
Clinical trial NCT06492629 · UNKNOWN
Trial details
- NCT number
- NCT06492629
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-03
- Primary completion
- 2025-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.